Molecular imaging in cancer - PubMed (original) (raw)

. 2006 May 26;312(5777):1168-71.

doi: 10.1126/science.1125949.

Affiliations

• PMID: 16728630
• DOI: 10.1126/science.1125949

Molecular imaging in cancer

Ralph Weissleder. Science. 2006.

Abstract

Medical imaging technologies have undergone explosive growth over the past few decades and now play a central role in clinical oncology. But the truly transformative power of imaging in the clinical management of cancer patients lies ahead. Today, imaging is at a crossroads, with molecularly targeted imaging agents expected to broadly expand the capabilities of conventional anatomical imaging methods. Molecular imaging will allow clinicians to not only see where a tumor is located in the body, but also to visualize the expression and activity of specific molecules (e.g., proteases and protein kinases) and biological processes (e.g., apoptosis, angiogenesis, and metastasis) that influence tumor behavior and/or response to therapy. This information is expected to have a major impact on cancer detection, individualized treatment, and drug development, as well as our understanding of how cancer arises.

PubMed Disclaimer

Similar articles

• Molecular imaging of breast cancer: present and future directions.
  Alcantara D, Leal MP, García-Bocanegra I, García-Martín ML. Alcantara D, et al. Front Chem. 2014 Dec 18;2:112. doi: 10.3389/fchem.2014.00112. eCollection 2014. Front Chem. 2014. PMID: 25566530 Free PMC article. Review.
• Conventional and novel PET tracers for imaging in oncology in the era of molecular therapy.
  Pantaleo MA, Nannini M, Maleddu A, Fanti S, Ambrosini V, Nanni C, Boschi S, Biasco G. Pantaleo MA, et al. Cancer Treat Rev. 2008 Apr;34(2):103-21. doi: 10.1016/j.ctrv.2007.10.001. Epub 2007 Dec 4. Cancer Treat Rev. 2008. PMID: 18055120 Review.
• Molecular-genetic imaging based on reporter gene expression.
  Kang JH, Chung JK. Kang JH, et al. J Nucl Med. 2008 Jun;49 Suppl 2:164S-79S. doi: 10.2967/jnumed.107.045955. J Nucl Med. 2008. PMID: 18523072 Review.
• Affibody molecules: new protein domains for molecular imaging and targeted tumor therapy.
  Nilsson FY, Tolmachev V. Nilsson FY, et al. Curr Opin Drug Discov Devel. 2007 Mar;10(2):167-75. Curr Opin Drug Discov Devel. 2007. PMID: 17436552 Review.
• Radiopharmaceuticals: molecular imaging using positron emission tomography.
  Antoni G, Långström B. Antoni G, et al. Handb Exp Pharmacol. 2008;(185 Pt 1):177-201. doi: 10.1007/978-3-540-72718-7_9. Handb Exp Pharmacol. 2008. PMID: 18626804 Review.

Cited by

• Polymeric Nanoparticles for Drug Delivery: Recent Developments and Future Prospects.
  Begines B, Ortiz T, Pérez-Aranda M, Martínez G, Merinero M, Argüelles-Arias F, Alcudia A. Begines B, et al. Nanomaterials (Basel). 2020 Jul 19;10(7):1403. doi: 10.3390/nano10071403. Nanomaterials (Basel). 2020. PMID: 32707641 Free PMC article. Review.
• Optical imaging of cancer-related proteases using near-infrared fluorescence matrix metalloproteinase-sensitive and cathepsin B-sensitive probes.
  Yhee JY, Kim SA, Koo H, Son S, Ryu JH, Youn IC, Choi K, Kwon IC, Kim K. Yhee JY, et al. Theranostics. 2012;2(2):179-89. doi: 10.7150/thno.3716. Epub 2012 Feb 10. Theranostics. 2012. PMID: 22375156 Free PMC article.
• Self-assembled polyelectrolyte nanoparticles as fluorophore-free contrast agents for multicolor optical imaging.
  Shin DH, Heo MB, Lim YT. Shin DH, et al. Molecules. 2015 Mar 9;20(3):4369-82. doi: 10.3390/molecules20034369. Molecules. 2015. PMID: 25759954 Free PMC article.
• Clinically-translated silica nanoparticles as dual-modality cancer-targeted probes for image-guided surgery and interventions.
  Bradbury MS, Phillips E, Montero PH, Cheal SM, Stambuk H, Durack JC, Sofocleous CT, Meester RJ, Wiesner U, Patel S. Bradbury MS, et al. Integr Biol (Camb). 2013 Jan;5(1):74-86. doi: 10.1039/c2ib20174g. Integr Biol (Camb). 2013. PMID: 23138852 Free PMC article.
• GX1-conjugated poly(lactic acid) nanoparticles encapsulating Endostar for improved in vivo anticolorectal cancer treatment.
  Du Y, Zhang Q, Jing L, Liang X, Chi C, Li Y, Yang X, Dai Z, Tian J. Du Y, et al. Int J Nanomedicine. 2015 May 28;10:3791-802. doi: 10.2147/IJN.S82029. eCollection 2015. Int J Nanomedicine. 2015. PMID: 26060399 Free PMC article.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Miscellaneous

  • NCI CPTAC Assay Portal